• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, January 30, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study illuminates sugar’s role in common kidney disease

Bioengineer by Bioengineer
January 5, 2023
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A study of kidney organoids in a novel lab environment might have downstream implications for the treatment of polycystic kidney disease (PKD), an incurable condition that affects more than 12 million people worldwide.

1-PKD cyst expansion

Credit: Benjamin Freedman Lab / University of Washington School of Medicine

A study of kidney organoids in a novel lab environment might have downstream implications for the treatment of polycystic kidney disease (PKD), an incurable condition that affects more than 12 million people worldwide.

One key discovery of the study: Sugar appears to play a role in the formation of fluid-filled cysts that are PKD’s hallmark. In people, these cysts grow big enough to impair kidney function and ultimately cause the organs to fail, necessitating dialysis therapy or transplant.

The findings were published in Nature Communications. The co-lead authors are Sienna Li and Ramila Gulieva, research scientists in the lab of Benjamin Freedman, a nephrology investigator at the University of Washington School of Medicine.

“Sugar uptake is something that kidneys do all the time,” said Freedman, a co-senior author. “We found that increasing the levels of sugar in the dish cultures caused cysts to swell. And when we employed drugs known to block sugar absorption in the kidneys, it blocked this swelling. But I think it relates less to blood sugar level and more to how kidney cells take in sugar — which in this process seemed to go rogue and give rise to cysts.”

For years Freedman has studied PKD in organoids grown from pluripotent stem cells.  Organoids resemble miniature kidneys: They contain filtering cells connected to tubes and can respond to infection and therapeutics in ways that parallel the responses of kidneys in people.

Although his team can grow organoids that give rise to PKD cysts, the mechanisms of those cysts’ formation are not yet understood. In this investigation, the researchers focused on how the flow of fluid within the kidney contributes to PKD.

To do so, they invented a new tool that merged a kidney organoid with a microfluidic chip. This allowed a combination of water, sugar, amino acids and other nutrients to flow over organoids that had been gene-edited to mimic PKD. 

“We were expecting the PKD cysts in the organoids to get worse under flow because the disease is associated with the physiological flow rates that we were exploring,” Freedman explained. “The surprising part was that the process of cyst-swelling involved absorption: the intake of fluid inward through cells from outside the cyst. That’s the opposite of what is commonly thought, which is that cysts form by pushing fluid outward through cells. It’s a whole new way of thinking about cyst formation.”

In the chips, the researchers observed that the cells lining the walls of the PKD cysts faced outward as they stretched and swelled, such that the tops of the cells were on the outside of the cysts. This inverted arrangement — these cells would be facing inward in living kidneys — suggests that cysts grow by pulling in sugar-rich fluid, not by secreting the liquid.

The observation gives researchers more information about how cysts form in organoids, a finding that will have to be tested further in vivo. As well, the fact that sugar levels drive cyst development points to new potential therapeutic options.

“The results of the experiment are significant because there is a whole class of molecules that block sugar uptake in the kidneys and are attractive therapeutics for a number of conditions,” Freedman said. “They haven’t been tested yet, but we view this as a proof-of-concept that these drugs could potentially help PKD patients.”

Dr. Jonathan Himmelfarb, professor of medicine (nephrology) at the UW School of Medicine, was a co-senior author of the paper.

The work was supported by the National Institutes of Health (UG3TR002158, UG3TR003288, UG3TR000504, K01DK102826, R01DK117914, U01DK127553, UC2DK126006, U01HL152401), a Novo Nordisk-sponsored research award, a gift from the Northwest Kidney Centers to the Kidney Research Institute, the Lara Nowak Macklin Research Fund, a gift from the Mount Baker Foundation, and startup funds from the University of Washington.

A competing interests statement can be found in the Nature Communications paper or may be obtained by contacting [email protected]



Journal

Nature Communications

DOI

10.1038/s41467-022-35537-2

Method of Research

Experimental study

Subject of Research

Human tissue samples

Article Title

Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease

Article Publication Date

23-Dec-2022

COI Statement

N.M.C. and B.S.F. are inventors on patents and/or patent applications related to human kidney organoid differentiation and modeling of PKD in this system (these include “Three-dimensional differentiation of epiblast spheroids into kidney tubular organoids modeling human microphysiology, toxicology, and morphogenesis” [Japan, US, and Australia], licensed to STEMCELL Technologies; “High-throughput automation of organoids for identifying therapeutic strategies” [PTC patent application pending]; “Systems and methods for characterizing pathophysiology” [PTC patent application pending]). B.S.F. and H.F. have ownership interest in Plurexa LLC. None of the preceding interests affected in any way the results of the paper or would be affected by them, but they are shared by way of transparency. All other authors declare no competing interests.

Share12Tweet8Share2ShareShareShare2

Related Posts

The two strategies that mutant measles viruses use to infect the brain

Measles virus ‘cooperates’ with itself to cause fatal encephalitis

January 27, 2023
Ólafsdóttir & Lind

Testing a immunological drug as a new treatment for early type 1 diabetes

January 27, 2023

Study shows FDA-approved TB regimen may not work against the deadliest form of TB due to multidrug-resistant strains

January 27, 2023

Non-invasive neurotechnology reduces symptoms of insomnia and improves autonomic nervous system function

January 27, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    64 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

People with arthritis 20% less likely to be in work

A fairy-like robot flies by the power of wind and light

UK’s Overseas Territories at ongoing risk from wide range of invasive species

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 43 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In